Skip to content

Insider · CIK 0001316851

Ted C Nark

director

Files at AMRX (Amneal Pharmaceuticals, Inc.). First filing Nov 19, 2025, latest Nov 19, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $586k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

AMRX: Amneal Pharmaceuticals, Inc.

AMRXOct 9, 2026 · close 19.91

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
47Moderate
AMRXsell 2
Amneal Pharmaceuticals, Inc.
$586k
50,000 shares
-15%+66% from low-3% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Nov 17, 2025AMRX
Amneal Pharmaceuticals, Inc.
SOpen-market sale
Class A Common Stock
-50,000$11.72$586k291,029Nov 19, 2025
May 5, 2025AMRX
Amneal Pharmaceuticals, Inc.
MOption exercise
Class A Common Stock
+40,258--341,029May 8, 2025
May 5, 2025AMRX
Amneal Pharmaceuticals, Inc.
MOption exercise
Restricted Stock Unitsderivative
-40,258$0.00$00May 8, 2025
May 6, 2025AMRX
Amneal Pharmaceuticals, Inc.
AGrant or award
Restricted Stock Unitsderivative
+34,819$0.00$034,819May 8, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Ted C Nark: insider trades and track record | InsiderTell